Skylato is a modern, hybrid-indica strain for which the exact origins and breeding history remain undocumented. Because information regarding its development is limited, breeders have not publicly confirmed a definitive lineage or specific crossing history, leaving its precise genetic background a subject of uncertainty. Given this lack of formal documentation, there is no verified breeder description or established context regarding its creation, and it should be categorized as a strain of unclear ancestry within the contemporary market.

The sensory profile of Skylato is defined by a complex range of terpenes, led by caryophyllene and followed by limonene, humulene, nerolidol, myrcene, linalool, beta-pinene, and pinene. Regarding its cannabinoid content, the strain features an estimated 19.3% THC concentration, an estimated 0% CBD, and an estimated 0.3% CBG. Its chemical composition suggests a nuanced aromatic and flavor profile that relies on this specific layering of terpenes, which represent the confirmed laboratory findings for the cultivar.

Skylato produces functional, balanced effects that leave users feeling relaxed and focused. It is commonly utilized by patients seeking relief from pain, stress, and sleep difficulties. Designed for both indoor and outdoor cultivation, the plant is considered of moderate difficulty to grow, typically reaching maturity after a 54-day flowering period and capable of producing a high yield. There are currently no notable offspring recorded for this strain.